Nasal NK/T cell lymphoma presenting as transverse myelopathy

Virchows Archiv

Volumn 436, Issue 4, 2000, Pages 393-397

  Sadahira, Yoshito ^a   Wada, Hideho ^a   Nakamura, Etsuko ^a   Terayama, Kiyomi ^a   Sugihara, Takashi ^a   Yamada, Osamu ^a   Mikami, Yoshiki ^a   Shirabe, Teruo ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

CNS; Demyelination; Lymphoma; Myelopathy; NK cell

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC FACTOR; DOXORUBICIN; ETOPOSIDE; GRANZYME B; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; VINCRISTINE; VIRUS RNA;

ADULT; ARTICLE; BRAIN CORTEX; CANCER MORTALITY; CASE REPORT; CELL GRANULE; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATION; EDEMA; EPSTEIN BARR VIRUS; EYELID DISEASE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPHOID CELL; MALE; NATURAL KILLER CELL; NOSE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL CORD DISEASE; SPINAL CORD ISCHEMIA; SPINAL ROOT; SUBARACHNOID SPACE; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

EID: 0034101814     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050465     Document Type: Article

References (16)

1. Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH (1997) Non-nasal lymphoma expressing the natural killer cell marker CD56: clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501-4513
2. Grant JW, Kaech D, Jones DB (1986) Spinal cord compression as the first presentation of lymphoma-a review of 15 cases. Histopathology 10:1191-1202
3. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC (1996) Report of the workshop on nasal and related extranodal angiocentric T/Natural Killer cell lymphomas. Am J Surg Pathol 20:103-111
4. Jellinger K, Radaszkiewicz T (1976) Involvement of the central nervous system in malignant lymphomas. Virchows Arch [A] 370:345-362
5. Lackowski D, Koberda L, deLoughery TG, So Y (1998) Natural killer cell leukemia as a cause of peripheral neuropathy and meningitis: case report. Neurology 51:640-641
6. Mckelvey EM, Gottlieb JA, Wilson HE, McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Gutterman J, Coltman C, Moon TE (1976) Hydroxydaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484-1493
7. Mechterscheimer G, Staudter M, Moller P (1991) Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res 51:1300-1307
8. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike K, Komatsu H, Iida S, Kagami Y, Ogura M, Katoh E et al. (1995) Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 19:284-296
9. Pant SS, Asbury AK, Richardson EP Jr (1968) The myelopathy of pernicious anemia. Acta Neurol Scand [Suppl] 44:4-36
10. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 312:874-879
11. Ranheim TS, Edelman GM, Cunnigham BA (1996) Homophilic adhesion mediated by the neural cell adhesion molecule involves multiple immunoglobulin domains. Proc Natl Acad Sci USA 93:4071-4075
12. Sadahira Y, Ohmoto K, Yamamoto S, Nishihara H, Wada H, Yawata Y, Manabe T (1998) Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis. Pathol Int 48:695-704
13. Van Gorp J, De Bruin PC, Sie-Go DM, Heerde P van, Ossenkoppele GJ, Rademakers LH, Meijer CJ, Tweel JG van den (1995) Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 27:139-148
14. Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA, Romaguera J, Rubenstein E, Cabanillas F (1994) ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 12:1169-1176
15. Wong KF, Chan JK, Ng CS (1994) CD56 (NCAM)-positive malignant lymphoma. Leuk Lymphoma 14:29-36
16. Yeh K, Lien H, Hsu S, Cheng A (1999) Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma. Am J Heamtol 60:161-163